SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $170.9 million in its fourth quarter.
The South Plainfield, New Jersey-based company said it had a loss of $2.35 per share.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.96 per share.
The biopharmaceutical company posted revenue of $167.4 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $179.2 million.
For the year, the company reported a loss of $559 million, or $7.79 per share. Revenue was reported as $698.8 million.
PTC Therapeutics expects full-year revenue in the range of $940 million to $1 billion.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.